Laprituximab emtansine (IMGN-289) is an immunotoxin targeting HER1. Laprituximab emtansine is an EGFR antibody-drug conjugate (ADC) consisting of the J2898A antibody, DM1 (anti-microtubule agent) and the SMCC thioether linker. Laprituximab emtansine can be used for cancer research[1][2][3].
Purity:
97.66
CAS Number:
[1622327-37-0]
Target:
Antibody-Drug Conjugates (ADCs),EGFR
Application Notes:
ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted